Fandy, Tamer E <br/><br/>
Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Oct 2006 
 - 471-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s00280-005-0184-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antifungal Agents--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--pharmacology<br/>Caspase 8<br/>Caspases--drug effects<br/>DNA Primers--genetics<br/>Down-Regulation--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Humans<br/>Hydroxamic Acids--pharmacology<br/>Membrane Glycoproteins--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--drug effects<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>TNF-Related Apoptosis-Inducing Ligand<br/>Tumor Cells, Cultured<br/>Tumor Necrosis Factor-alpha--pharmacology